Meridian Bioscience is a life science company which develops, manufactures, distributes, and sells diagnostic test kits primarily for various gastrointestinal and viral diseases, respiratory and parasitic infectious diseases, and elevated blood lead levels worldwide. The Company offers testing platforms and technologies. These products are primarily used in the detection of infectious diseases caused by various bacteria, viruses, parasites, and pathogens.The Company also provides bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies.

Type
Public
HQ
Cincinnati, US
Founded
1977
Size (employees)
640 (est)
Meridian Bioscience was founded in 1977 and is headquartered in Cincinnati, US
Report incorrect company information

Meridian Bioscience Office Locations

Meridian Bioscience has offices in Schijndel, Paris, Braine-l'Alleud, Eveleigh and in 5 other locations
Cincinnati, US (HQ)
3471 River Hills Drive
Memphis, US
5171 Wilfong Road
Eveleigh, AU
Suite G16A, NIC Building Australian Technology Park
Braine-l'Alleud, BE
2 Avenue du Japon
Paris, FR
34 Rue de Ponthieu
Luckenwalde, DE
3 Im Biotechnologiepark
Show all (9)
Report incorrect company information

Meridian Bioscience Financials and Metrics

Meridian Bioscience Financials

Meridian Bioscience's revenue was reported to be $200.77 m in FY, 2017
USD

Revenue (FY, 2017)

200.8 m

Gross profit (FY, 2017)

124.8 m

Gross profit margin (FY, 2017), %

62.2%

Net income (FY, 2017)

21.6 m

EBIT (FY, 2017)

37.4 m

Market capitalization (20-Apr-2018)

620.7 m

Cash (30-Sep-2017)

57.1 m

EV

618.3 m
Meridian Bioscience's current market capitalization is $620.7 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

188.7 m188.8 m194.8 m196.1 m200.8 m

Revenue growth, %

0%3%1%

Cost of goods sold

67.6 m71.6 m72.9 m68.3 m75.9 m

Gross profit

121 m117.2 m121.9 m127.8 m124.8 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

44.8 m50.1 m47.2 m48 m51.5 m48.2 m47.2 m51.3 m50.7 m46.8 m54.1 m50.1 m

Cost of goods sold

16.8 m18.5 m18 m18.8 m19 m17.9 m15.6 m17.7 m17.8 m17.4 m20.6 m18.9 m

Gross profit

28 m31.6 m29.2 m29.2 m32.5 m30.3 m31.6 m33.6 m32.9 m29.5 m33.5 m31.2 m

Gross profit Margin, %

63%63%62%61%63%63%67%65%65%63%62%62%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

44.3 m43 m50 m47.2 m57.1 m

Accounts Receivable

Inventories

34.8 m35.5 m35.8 m45.1 m41.5 m

Current Assets

114.1 m112.7 m122.9 m126.8 m133.9 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

43.7 m38.2 m39.3 m49.5 m42.7 m46 m53.4 m48.9 m45.8 m49.3 m54.7 m55.3 m

Inventories

37.7 m38.1 m37.6 m34.4 m33 m33.6 m38.8 m41.9 m43.4 m44.7 m42.4 m40.9 m

Current Assets

111.2 m114 m113.5 m114.7 m116.5 m118 m123.2 m128.2 m126.9 m126 m128.8 m129.2 m

Goodwill

23.4 m23.5 m23.8 m22.6 m22.1 m22.8 m22.1 m64.5 m63.7 m60.7 m60.8 m54.6 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

38 m34.7 m35.5 m32.2 m21.6 m

Inventories

41.5 m

Accounts Payable

7.7 m

Cash From Operating Activities

44.4 m38.3 m42.8 m37.2 m41.4 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

7.4 m10.3 m8.8 m7.9 m10.1 m27.1 m8.9 m18 m26.7 m6.3 m15.6 m15.8 m

Inventories

33.6 m38.8 m41.9 m43.4 m44.7 m42.4 m

Accounts Payable

5.5 m7.2 m7.9 m7.4 m7.5 m6.4 m

Dividends Paid

(25 m)(8.4 m)(16.8 m)(25.2 m)(8.4 m)(13.7 m)(19 m)
USDY, 2017

EV/EBIT

16.5 x

EV/CFO

15 x

Revenue/Employee

310.5 k

Debt/Equity

0.3 x

Debt/Assets

0.2 x

Financial Leverage

1.5 x
Show all financial metrics
Report incorrect company information